Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer. A Single Center Study

NCT07287592 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07287592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07287592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer. A Single Center Study
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 30, 2025
Completion date
April 30, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neuropathy